Last $104.76 USD
Change Today +0.41 / 0.39%
Volume 690.5K
MJN On Other Exchanges
Symbol
Exchange
New York
As of 4:15 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

mead johnson nutrition co (MJN) Key Developments

Mead Johnson Nutrition Company Appoints Michael A. Sherman as Director and Member of Audit Committee

On February 26, 2015, the board of directors of Mead Johnson Nutrition Company (the company) appointed Michael A. Sherman, effective immediately, to fill the vacancy created by the increase in the number of directors. Upon recommendation of the Nominating and Corporate Governance Committee, the board also appointed Mr. Sherman to serve as a member of the company's audit committee. Mr. Sherman currently serves as the chief operating officer and chief financial officer of Endocyte Inc. He has served as Endocyte's chief financial officer since 2006, and was also appointed as the chief operating officer in 2014.

Mead Johnson Nutrition Company Declares Quarterly Dividend, Payable on April 1, 2015

Mead Johnson Nutrition Company announced that its board of directors has declared a regular quarterly dividend of $0.4125 per share for the quarter ending March 31, 2015, an increase of 10% from the prior rate of $0.375 per share. The board expects the annualized dividend to be $1.65 per share. The dividend will be paid at the new higher rate on April 1, 2015, to shareholders of record at close of business on March 16, 2015.

Mead Johnson Nutrition Mulls Acquisition

Mead Johnson Nutrition Company (NYSE:MJN) is seeking acquisitions. Pete Leemputte, Chief Financial Officer of Mead Johnson Nutrition, said in FirstService Corporation earnings call, “But we reiterate that growth is the highest priority for our use of cash and we intend to pursue potential acquisitions such as the deal in Argentina.”

Mead Johnson Nutrition Company Presents at Consumer Analyst Group of New York Conference, Feb-17-2015 09:15 AM

Mead Johnson Nutrition Company Presents at Consumer Analyst Group of New York Conference, Feb-17-2015 09:15 AM. Venue: Boca Raton Resort & Club, New York, New York, United States. Speakers: Kasper Jakobsen, president and chief executive officer, Peter G. Leemputte, Chief Financial Officer and Executive Vice President.

Mead Johnson Nutrition Company Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for the Full Year of 2015

Mead Johnson Nutrition Company announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported net sales of $1,094.2 million compared with $1,060.7 million for the same period a year ago. Earnings before interest and tax was $209.6 million compared with $203.9 million for the same period a year ago. Earnings before tax was $195.3 million compared with $192.2 million for the same period a year ago. Net earnings attributable to shareholders was $158.4 million or $0.78 per diluted share compared with $152.5 million or $0.75 per diluted share for the same period a year ago. Non GAAP, earnings before interest and income tax was $252.0 million compared with $227.5 million for the same period a year ago. Non GAAP, earnings before income tax was $237.7 million compared with $215.8 million for the same period a year ago. Non GAAP, net earnings attributable to shareholders was $186.2 million or $0.75 per diluted share compared with $167.2 million or $0.82 per diluted share for the same period a year ago. For the full year, the company reported net sales of $4,409.3 million compared with $4,200.7 million for the same period a year ago. Earnings before interest and tax was $988.3 million compared with $974.9 million for the same period a year ago. Earnings before tax was $928.0 million compared with $924.3 million for the same period a year ago. Net earnings attributable to shareholders was $719.8 million or $3.54 per diluted share compared with $683.8 million or $3.36 per diluted share for the same period a year ago. Net cash provided by operating activities was $793.4 million compared with $806.6 million for the same period a year ago. Payments for capital expenditures was $186.6 million compared with $240.4 million for the same period a year ago. Non GAAP, earnings before interest and income tax was $1,051.6 million compared with $1,008.1 million for the same period a year ago. Non GAAP, earnings before income tax was $991.3 million compared with $957.5 million for the same period a year ago. Non GAAP, net earnings attributable to shareholders was $759.4 million or $3.74 per diluted share compared with $714.7 million or $3.51 per diluted share for the same period a year ago. The company provided earnings guidance for the full year of 2015. The company look forward to continued success in 2015 and expects constant dollar revenue growth around 7%. As it enters 2015, its faces significant headwinds from a strengthening dollar. Approximately three quarters of revenue is in foreign currencies while much of its cost base is dollar denominated. As a result, its earnings are somewhat exposed to currency fluctuations. Lower commodity costs will, however, allow it to improve gross margins and invest incrementally behind its brands. The company expects 2015 non-GAAP EPS in the range of $3.90 to $4.00. The company expects reported sales growth to be approximately 3%, which includes adverse foreign exchange of 4%. Specified Items are currently expected to be $0.05 per diluted share excluding any MTMadjustments. As a result, full year GAAP EPS is expected to be in the range of $3.85 to $3.95.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MJN:US $104.76 USD +0.41

MJN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott India Ltd 3,776 INR -42.85
Inner Mongolia Yili Industrial Group Co Ltd CNY28.24 CNY -0.29
Perrigo Co PLC $154.47 USD -0.78
Hain Celestial Group Inc/The $62.53 USD -0.20
Yakult Honsha Co Ltd ¥7,580 JPY +90.00
View Industry Companies
 

Industry Analysis

MJN

Industry Average

Valuation MJN Industry Range
Price/Earnings 29.5x
Price/Sales 4.8x
Price/Book 37.0x
Price/Cash Flow 29.4x
TEV/Sales 4.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEAD JOHNSON NUTRITION CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.